Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Lavin

Showing results (21-30 of 148) with videos related to

Pageof 15
Sort By:
Cancer Treatment Reports|June 1, 1976
Nitrosoureas: useful agents for the treatment of advanced gastrointestinal cancerH O Douglass, P T Lavin, C G Moertel
American Journal of Clinical Oncology|June 1, 1985
Hematologic toxicity of cisplatin and mitomycin in combination for squamous cell carcinoma of esophagusD B Stoll, P T Lavin, P F Engstrom
Cancer Treatment Reports|July 1, 1982
Phase II trial of doxorubicin therapy for advanced islet cell carcinomaC G Moertel, P T Lavin, R G Hahn
Clinical Therapeutics|May 1, 1993
Efficacy and tolerability of a combination of enalapril and hydrochlorothiazide in the treatment of hypertension measured manually and with an ambulatory blood pressure monitorM R Weir, P T Lavin, C A Byrnes
Clinical Therapeutics|March 1, 1991
The efficacy and tolerability of famotidine and ranitidine on the healing of active duodenal ulcer and during six-month maintenance treatment, with special reference to NSAID/aspirin-related ulcersS Bank, R E Greenberg, D Magier, et al.
Journal of Drug Education|January 1, 1992
"The responsibility to inform, the power to act": a conference for New England college newspaper editors on the role of the campus press in addressing substance use issuesH Wechsler, W DeJong, G R Shapiro, et al.
Medical Devices (Auckland, N.Z.)|July 30, 2016
A method for establishing class III medical device equivalence: sodium hyaluronate (GenVisc 850) for the treatment of knee osteoarthritisGheorghe Doros, Philip T Lavin, Michael Daley, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|January 23, 2020
Why correctly identifying maternal condition in perinatal death classification systems is crucial: a commentaryT Lavin, D B Preen, E Allanson, et al.
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|July 4, 2019
INTERGROWTH-21st v. local South African growth standards (Theron-Thompson) for identification of small-for-gestational-age fetuses in stillbirths: A closer look at variation across pregnancyT Lavin, L Nedkoff, D Preen, et al.
Journal of Endodontics|August 7, 1998
Cytotoxicity of root perforation repair materialsH A Makkawy, S Koka, M T Lavin, et al.
Pageof 15

Showing results (21-30 of 148) with videos related to

Sort By:
Pageof 15
Cancer Treatment Reports|June 1, 1976
Nitrosoureas: useful agents for the treatment of advanced gastrointestinal cancerH O Douglass, P T Lavin, C G Moertel
American Journal of Clinical Oncology|June 1, 1985
Hematologic toxicity of cisplatin and mitomycin in combination for squamous cell carcinoma of esophagusD B Stoll, P T Lavin, P F Engstrom
Cancer Treatment Reports|July 1, 1982
Phase II trial of doxorubicin therapy for advanced islet cell carcinomaC G Moertel, P T Lavin, R G Hahn
Clinical Therapeutics|May 1, 1993
Efficacy and tolerability of a combination of enalapril and hydrochlorothiazide in the treatment of hypertension measured manually and with an ambulatory blood pressure monitorM R Weir, P T Lavin, C A Byrnes
Clinical Therapeutics|March 1, 1991
The efficacy and tolerability of famotidine and ranitidine on the healing of active duodenal ulcer and during six-month maintenance treatment, with special reference to NSAID/aspirin-related ulcersS Bank, R E Greenberg, D Magier, et al.
Journal of Drug Education|January 1, 1992
"The responsibility to inform, the power to act": a conference for New England college newspaper editors on the role of the campus press in addressing substance use issuesH Wechsler, W DeJong, G R Shapiro, et al.
Medical Devices (Auckland, N.Z.)|July 30, 2016
A method for establishing class III medical device equivalence: sodium hyaluronate (GenVisc 850) for the treatment of knee osteoarthritisGheorghe Doros, Philip T Lavin, Michael Daley, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|January 23, 2020
Why correctly identifying maternal condition in perinatal death classification systems is crucial: a commentaryT Lavin, D B Preen, E Allanson, et al.
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|July 4, 2019
INTERGROWTH-21st v. local South African growth standards (Theron-Thompson) for identification of small-for-gestational-age fetuses in stillbirths: A closer look at variation across pregnancyT Lavin, L Nedkoff, D Preen, et al.
Journal of Endodontics|August 7, 1998
Cytotoxicity of root perforation repair materialsH A Makkawy, S Koka, M T Lavin, et al.
Pageof 15